Chronic primary cervical pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 50-75 years; 2. Diagnostic criteria: Meet conditions A to C: A. Chronic pain (persist or recurring for more than 3 months) in the neck muscles, bones, joints, or tendons. B. The pain is associated with at least one the following: B.1 Emotional distress due to pain. B.2 Pain interferes with daily activities and social participation. C. Other diagnoses of chronic secondaryculoskeletal pain cannot better explain the pain; 3. Numerical Rating Scale (NRS) for pain >=4; 4. No history of neck or shoulder or surgeries; 5. No neurological diseases or metabolic disorders; 6. Willing to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with neck pain caused by severe local pathological changes or systemic diseases, such as tumors or rheumatoid arthritis; 2. Cervical spondylosis with radiculopathy, Cervical spondylosis with myelopathy 3. Those who have used other micro-needle therapies (acupuncture, abdominal acupuncture etc.) in the past 12 months; 4. Those who have used morphine or pethidine for pain relief in the past 6 months; those allergic to non-steroidal anti-inflammatory drugs; those currently taking or injecting anticoagulants; 5. Those with adverse reactions to acupuncture (such fainting); 6. Pregnant or lactating women; 7. Those with other serious diseases such as heart, liver, or kidney diseases; 8. Patients infections, wounds, or who have undergone facial cosmetic surgery in the facial or neck area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-rating Anxiety Scale;Patient Health Questionnaire-9;Neck Disability Index;cervical range of motion;Global Rating of Change Scale;The usage and frequency of non-steroidal anti-inflammatory drugs;The average pain intensity of neck pain within 6 months after treatment;Heartbeat tracking task;The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2);interoceptive awareness;Changes in inflammatory factors (PGE2, COX-2) ; | — |
Countries
China
Contacts
Beijing Hospital